Response to FOLFIRINOX by gender in patients with metastatic pancreatic cancer: Results from the PRODIGE 4/ ACCORD 11 randomized trial

BACKGROUND: Hohla et al. suggested that female gender could positively predict response to FOLFIRINOX in patients with advanced pancreatic cancer. In this study, we explored the response to the FOLFIRINOX regimen by gender within the trial PRODIGE4/ACCORD 11. PATIENTS AND METHODS: Data were describe...

Descripción completa

Detalles Bibliográficos
Autores principales: Lambert, Aurélien, Jarlier, Marta, Gourgou Bourgade, Sophie, Conroy, Thierry
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5606928/
https://www.ncbi.nlm.nih.gov/pubmed/28931010
http://dx.doi.org/10.1371/journal.pone.0183288

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5606928/
https://www.ncbi.nlm.nih.gov/pubmed/28931010
http://dx.doi.org/10.1371/journal.pone.0183288

Ejemplares similares